Prior Authorization Drug List

Similar documents
Specialty Drugs. The following is a list of medications that are considered to be specialty drugs. Specialty drugs

Specialty Drugs. The specialty drug list below is effective June 5, 2018 and is subject to change at any time.

Pulmonary Hypertension Weight Loss Skin Conditions. Skin Conditions Multiple Sclerosis Endocrine Disorder. Endocrine Disorder.

DRUGS REQUIRING PRIOR AUTHORIZATION

METABOLIC, IMMUNE DISORDERS OR INHERITED RARE DISEASE ALPHA-1 PROTEINASE INHIBITORS ARANESP BLOOD CELL DEFICIENCY ARANESP ARCALYST

Prior Authorization Drug List

2018 BCN Advantage Prior Authorization Criteria Last updated: April, 2018

2018 BCN Advantage Prior Authorization Criteria Last updated: November, 2017

Department of Origin: Integrated Healthcare Services. Approved by: Chief Medical Officer Department(s) Affected: Date approved: 01/10/17

Prior Authorization Program Information (Effective April 1st, 2018)

acromegaly Drugs Covered Uses Exclusion Criteria Required Medical Information Age Restriction Prescriber Restriction Coverage Duration

01/10/17. Replaces Effective Policy Dated: Amino Acid Based Elemental Formula (AABF) 09/28/15 Reference #: MP/A003 Page: 1 of 3

FYI ONLY Generic Name. Generics available. zoledronic acid N/A

01/26/17. Replaces Effective Policy Dated: Autism Spectrum Disorders in Children: Assessment 01/19/16 and Evaluation Reference #: MP/A005 Page 1 of 4

PURPOSE: The intent of this policy is to provide guidelines for coverage of dental procedures under the medical benefit.

Quantity Limit Drug List

Quantity Limit Drug List

B. To assess an individual when clinical evaluation suggests use of non-prescribed medications or illegal substances; or

LIMITED DISTRIBUTION MEDICATIONS

Santa Clara Family Health Plan Cal MediConnect Plan (Medicare-Medicaid Plan) 2017 Drug List

Approved by: Integrated Health Quality Management Subcommittee Effective Date: Department of Origin: Integrated Healthcare Services.

Specialty Drug List - Sorted by Therapeutic Class Developed for the Mississippi Division of Medicaid by Mercer

3 Tier Formulary Additions

CENTENE PHARMACY & THERAPEUTICS COMMITTEE SECOND QUARTER 2017 AMBETTER GUIDELINE SUMMARY. Revision Summary or Description

Prior Authorization Drug List

03/13/18. A. Symptoms lasting for greater than or equal to 12 months that have resulted to significant impairment in activities of daily living; and

ALPHA1-PROTEINASE INHIBITOR

06/13/17. A. Completed a comprehensive diabetes education program within the past two years; and

Reason for change. Recently approved. Recently approved. Recently approved. Recently approved. Recently updated. Recently approved.

Lista de medicamentos especializados

ICP Formulary Updates

after reconstitution No Yes Refrigerate; do Not freeze. Discard unused portions; do Not save for further Immune Deficiencies & Related

Pharmacy Benefit Management (PBM) Program FORMULARY/PRODUCT RESTRICTIONS

09/12/17. I. Electrical Bone Growth Stimulator (invasive, semi-invasive, or non-invasive) any of the following: A-C

03/14/17. II. Initial early intensive-level behavioral and developmental therapy must have both of the following: A and B

Step Therapy Criteria

Date approved: 04/18/18. Approved by: Pharmacy and Therapeutics Quality Management Subcommittee Effective Date: Department of Origin: Pharmacy

PHARMACY AND THERAPEUTICS COMMITTEE 4 th Quarter 2017

Exclusion Reasons Presumption of Long- Term Non-Acute Administration C9399 Unclassified Drugs or

Trusted Health Plan Formulary

GA KS KY LA MD NJ NV NY TN TX WA Applicable X N/A N/A X N/A X X X X X X N/A N/A X *FHK- Florida Healthy Kids. ADHD Narcolepsy

Quantity Limit Drug List

Central Nervous System Stimulants Drug Class Prior Authorization Protocol

Drug Quantity Limits

Calendar Year Deductible Annual Benefit Maximum. ADA Code Covered Services Member pays. n/a Office visit $5 per visit

Clinical Policy: Atomoxetine (Strattera) Reference Number: CP.PST.17 Effective Date:

Generic Label Name Drug Strength Dosage Form Example Product (s) MME/Unit ACETAMINOPHEN WITH CODEINE

Ally Rx D-SNP Current as of r 1, 2017

Updates to your prescription benefits

2018 Preventive Schedule

Cerebral Stimulant and ADHD Drugs Prior Authorization Request

Approval of a drug under this criteria document does not ensure full coverage of the drug.

Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document.

ADCIRCA. Products Affected Adcirca. Prior Authorization Criteria 2017 MMP Effective Date: 11/01/2017 Approval Date: 11/01/2017

ABRAXANE. Products Affected. Prior Authorization Criteria 2019 Secure-Extra PDP 6 Tier Last Updated: 12/2018. Abraxane

ADHD Medications Table

Trusted Health Plan Formulary

Smile SM Value 50/1500/No Ortho/MAC

OVERVIEW FOOD AND DRUG ADMINISTRATION-APPROVED INDICATIONS

Pequot Health Care Opioid Analgesic Quantity Program*

Calendar Year Deductible Annual Benefit Maximum. ADA Code Covered Services Member pays

APOKYN (apomorphine hydrochloride)

Drug Quantity Limits

Updates to your prescription benefits

Alameda Alliance for Health Pharmacy & Therapeutics (P&T) Committee Decisions

Smile SM Deluxe Gold 50/1500/Ortho/U85

DRUG TREND REPORT. WellDyneRx ANNUAL 1 2% 34% WellDyneRx. Diabetes MS Oncology Asthma/COPD HIV. Pain/inflammation. High Blood Choles Attention Disorde

Ultimate Health Plans (HMO)

Cigna Drug and Biologic Coverage Policy

Capital BlueCross Open/Closed Formulary Update (1 st Quarter 2017)

2014 Quantity Limits (QL) Criteria

Updates to your prescription benefits

Smile SM Plus 50/1500/Ortho/MAC

UnitedHealthcare Pharmacy Clinical Pharmacy Programs. Program Number 2017 P Prior Authorization/Notification CNS Stimulants

TYMLOS (abaloparatide)

Antidepressants: -amitriptyline -venlafaxine. Alpha-agonists: -clonidine -guanfacine. Beta blockers: -atenolol -nadolol. AEDs: -carbamazepine

Alprazolam 0.25mg, 0.5mg, 1mg tablets

** Fee-For-Service Pharmacy Provider Notice #232 September 2018 PDL Changes **

Pediatric Dental and Vision

PRESCRIPTION DRUGS REQUIRING PRIOR AUTHORIZATION

SOMATULINE DEPOT (lanreotide acetate)

ALPHA1-PROTEINASE INHIBITORS

Aetna Better Health. Specialty Drug Program

Quantity Limit Drug List

QUANTITY LIMIT CRITERIA

Opioid Management Program May 2018

STELARA (ustekinumab)

Tusculum College. Benefit Summary. $25 Copay. $25 Copay. after Deductible. 20% after Deductible 20% after Deductible

ACITRETIN. Products Affected

ABRAXANE. Products Affected. Prior Authorization Criteria 2019 Secure-Essential PDP 5 Tier Last Updated: 10/01/2018. Abraxane

GENETIC TESTING FOR PREDICTING RISK OF NONFAMILIAL BREAST CANCER

Diagnosis of severe congenital A1-PI deficiency who have clinically evident emphysema, weight, A1-PI phenotype, A1-PI baseline level

Pharmacy Medical Necessity Guidelines: ADHD CNS Stimulant Medications

Diagnosis of severe congenital A1-PI deficiency who have clinically evident emphysema, weight, A1-PI phenotype, A1-PI baseline level

LARTRUVO (olaratumab)

Prescription Drug Benefit Rider V

Transcription:

Prior Authorization Drug List This is a list of drugs that require Prior Authorization before coverage is provided. If you are prescribed a medication that requires Prior Authorization, your physician will need to contact PreferredOne at the number provided on your ID card to request a prior authorization review. PreferredOne will review the request to determine if the medication use is consistent with your benefit coverage and will notify you and your physician of the coverage determination. Without prior authorization approval, these drugs may not be covered by your pharmacy benefit. This list is subject to change throughout the year. The presence of a drug on this list does not guarantee coverage and not all drugs included on this list may be covered by your pharmacy benefit plan. Coverage of medications is determined your benefit plan. Your plan may require prior authorization for additional medications not included on this list. Drug Class ANALGESICS ACTIQ BELBUCA buprenorphine diclofenac sodium DUEXIS EMBEDA BUTRANS DOLOPHINE HCL DURAGESIC fentanyl fentanyl citrate FIORINAL WITH CODEINE #3 hydrocodone-ibuprofen LAZANDA lortab morphine sulfate er nalocet oxymorphone hcl er SPRIX HYSINGLA ER levorphanol tartrate methadone hcl MS CONTIN OXYCONTIN PENNSAID SUBSYS tramadol hcl er tramadol hcl-acetaminophen ULTRACET VIMOVO

ANESTHETICS ANTIBACTERIALS ANTICONVULSANTS ANTIEMETICS ANTIFUNGALS ANTIGOUT AGENTS ANTINEOPLASTICS XTAMPZA ER XIFAXAN ONFI vigabatrin BONJESTA DICLEGIS MARINOL ciclopirox SPORANOX KRYSTEXXA ALUNBRIG bexarotene CALQUENCE COTELLIC ELITEK FARYDAK GILOTRIF ICLUSIG IMBRUVICA KISQALI LONSURF NINLARO PROVENGE RUBRACA TARCEVA TEMODAR THALOMID SABRIL CESAMET dronabinol SYNDROS itraconazole BELEODAQ bortezomib capecitabine decitabine ERLEADA FOLOTYN HERCEPTIN imatinib mesylate JAKAFI KISQALI FEMARA CO-PACK MYLOTARG PORTRAZZA REVLIMID RYDAPT TARGRETIN temozolomide VERZENIO

ANTINEOPLASTICS -- Continued VOTRIENT ZEJULA XALKORI ZOLINZA ANTIPARASITICS ANTIPARKINSON AGENTS ANTIPSYCHOTICS ANTIVIRALS ZYKADIA ALBENZA quinine sulfate APOKYN OSMOLEX ER ADASUVE DAKLINZA MAVYRET PEGINTRON REDIPEN SELZENTRY TROGARZO VIEKIRA XR DARAPRIM DUOPA NUPLAZID EPCLUSA PEGASYS PROCLICK PREVYMIS TECHNIVIE VIEKIRA PAK BLOOD GLUCOSE REGULATORS AFREZZA GLUMETZA BLOOD PRODUCTS/MODIFIERS/VOLUME EXPANDERS MIRCERA chlorpropamide metformin hcl er 500 (generic for glumetza er) MOZOBIL CARDIOVASCULAR AGENTS PROCRIT CORLANOR JUXTAPID KYNAMRO PRALUENT PEN REPATHA PUSHTRONEX REPATHA SYRINGE VYTORIN ezetimibe-simvastatin KEVEYIS NORTHERA PRALUENT SYRINGE REPATHA SURECLICK simvastatin ZOCOR

CENTRAL NERVOUS SYSTEM AGENTS ADDERALL ADZENYS XR-ODT AUBAGIO AVONEX BETASERON ADZENYS ER AMPYRA AUSTEDO AVONEX PEN COPAXONE DERMATOLOGICAL AGENTS COTEMPLA XR-ODT DEXEDRINE dextroamphetamine sulfate dextroamphetamine-amphet er DYANAVEL XR FOCALIN glatiramer acetate HORIZANT metadate er METHYLIN methylphenidate hcl cd NUEDEXTA PLEGRIDY procentra QUILLIVANT XR REBIF riluzole RITALIN LA tetrabenazine VYVANSE zenzedi ZINBRYTA adapalene COSENTYX PEN DUPIXENT STELARA DESOXYN dexmethylphenidate hcl dextroamphetamine sulfate er dextroamphetamine-amphetamine EXTAVIA GILENYA glatopa INGREZZA methamphetamine hcl methylphenidate hcl methylphenidate la OCREVUS PLEGRIDY PEN QUILLICHEW ER RADICAVA REBIF REBIDOSE RITALIN TECFIDERA TYSABRI ZENZEDI ZENZEDI claravis DIFFERIN RETIN-A MICRO PUMP TALTZ SYRINGE (3 PACK)

ENZYME REPLACEMENT/MODIFIERS MEPSEVII GASTROINTESTINAL AGENTS alosetron hcl LOTRONEX RELISTOR XENICAL miglustat CHOLBAM OCALIVA VIBERZI XERMELO GENITOURINARY AGENTS CUPRIMINE HORMONAL AGENTS, STIMULANT/REPLACEMENT/MODIFYING (ADRENAL) EMFLAZA KORLYM HORMONAL AGENTS, STIMULANT/REPLACEMENT/MODIFYING (PITUITARY) GENOTROPIN H.P. ACTHAR NOVAREL HORMONAL AGENTS, STIMULANT/REPLACEMENT/MODIFYING (SEX HORMONES/MODIFIERS) ANADROL-50 ANDROGEL hydroxyprogesterone caproate methyltestosterone oxandrolone testosterone HORMONAL AGENTS, SUPPRESSANT (PARATHYROID) SENSIPAR MAKENA OXANDRIN TESTONE CIK testosterone cypionate HORMONAL AGENTS, SUPPRESSANT (PITUITARY) EGRIFTA FIRMAGON LUPRON DEPOT SIGNIFOR SOMATULINE DEPOT TRELSTAR ELIGARD LUPANETA PACK SANDOSTATIN SIGNIFOR LAR SUPPRELIN LA TRIPTODUR IMMUNOLOGICAL AGENTS VANTAS BERINERT GAMMAPLEX ILARIS CUVITRU HUMIRA PEN KEVZARA

IMMUNOLOGICAL AGENTS -- Continued ORENCIA OTREXUP OTEZLA RASUVO SYNAGIS METABOLIC BONE DISEASE AGENTS FORTEO PROLIA MISCELLANEOUS THERAPEUTIC AGENTS ADDYI AIMOVIG AUTOINJECTOR (2 PACK) CETROTIDE hydrocodone-chlorpheniramne er NUCALA REZIRA TUSSICAPS XURIDEN NATPARA XGEVA adipex-p benzphetamine hcl CONTRAVE hydrocodone-homatropine mbr ODACTRA supartz fx tussigon OPHTHALMIC AGENTS CYCLOSPORINE IN KLARITY LUXTURNA XIIDRA CYSTARAN RESTASIS MULTIDOSE RESPIRATORY TRACT/PULMONARY AGENTS ADEMPAS AUVI-Q DALIRESP OPSUMIT ORKAMBI sildenafil TRACLEER TYVASO INSTITUTIONAL START KIT ARALAST NP CAYSTON GRASTEK ORENITRAM ER REVATIO SYMDEKO TYVASO UPTRAVI SKELETAL MUSCLE RELAXANTS VENTAVIS BOTOX SLEEP DISORDER AGENTS armodafinil HETLIOZ flurazepam hcl modafinil

SLEEP DISORDER AGENTS -- Continued NUVIGIL XYREM THERAPEUTIC NUTRIENTS/MINERALS/ELECTROLYTES ENDARI JADENU EXJADE trientine hcl

PreferredOne Insurance Company Nondiscrimination Notice PreferredOne Insurance Company ( PIC ) complies with applicable Federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability, or sex. PIC does not exclude people or treat them differently because of race, color, national origin, age, disability, or sex. PIC: Provides free aids and services to people with disabilities to communicate effectively with us, such as: Qualified sign language interpreters Written information in other formats (large print, audio, accessible electronic formats, other formats) Provides free language services to people whose primary language is not English, such as: Qualified interpreters Information written in other languages If you need these services, contact a Grievance Specialist. If you believe that PIC has failed to provide these services or discriminated in another way on the basis of race, color, national origin, age, disability, or sex, you can file a grievance with: Grievance Specialist PreferredOne Insurance Company PO Box 59212 Minneapolis, MN 55459-0212 Phone: 1.800.940.5049 (TTY: 763.847.4013) Fax: 763.847.4010 Email: customerservice@preferredone.com You can file a grievance in person or by mail, fax, or email. If you need help filing a grievance, a Grievance Specialist is available to help you. You can also file a civil rights complaint with the U.S. Department of Health and Human Services, Office for Civil Rights, electronically through the Office for Civil Rights Complaint Portal, available at https://ocrportal.hhs.gov/ocr/portal/lobby.jsf, or by mail or phone at: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Complaint forms are available at http://www.hhs.gov/ocr/office/file/index.html. NDR PIC LV (1/18)

PreferredOne Community Health Plan Nondiscrimination Notice PreferredOne Community Health Plan ( PCHP ) complies with applicable Federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability, or sex. PCHP does not exclude people or treat them differently because of race, color, national origin, age, disability, or sex. PCHP: Provides free aids and services to people with disabilities to communicate effectively with us, such as: Qualified sign language interpreters Written information in other formats (large print, audio, accessible electronic formats, other formats) Provides free language services to people whose primary language is not English, such as: Qualified interpreters Information written in other languages If you need these services, contact a Grievance Specialist. If you believe that PCHP has failed to provide these services or discriminated in another way on the basis of race, color, national origin, age, disability, or sex, you can file a grievance with: Grievance Specialist PreferredOne Community Health Plan PO Box 59052 Minneapolis, MN 55459-0052 Phone: 1.800.940.5049 (TTY: 763.847.4013) Fax: 763.847.4010 customerservice@preferredone.com You can file a grievance in person or by mail, fax, or email. If you need help filing a grievance, a Grievance Specialist is available to help you. You can also file a civil rights complaint with the U.S. Department of Health and Human Services, Office for Civil Rights, electronically through the Office for Civil Rights Complaint Portal, available at https://ocrportal.hhs.gov/ocr/portal/lobby.jsf, or by mail or phone at: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C. 20201 1-800-368-1019, 800-537-7697 (TDD) Complaint forms are available at http://www.hhs.gov/ocr/office/file/index.html. NDR PCHP LV (1/18)